DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus
Introduction The aims of this study were to characterize insulin-treated individuals aged ≥75 years with type 2 diabetes using basal insulin analogs (BIA) or regular insulins (human insulin (HI)/neutral protamine Hagedorn (NPH)) and to compare the benefits and risks.Research design and methods The a...
Main Authors: | Peter Bramlage, Sascha R Tittel, Gesine van Mark, Reinhard Welp, Jörg Gloyer, Stefan Sziegoleit, Ralf Barion, Peter M Jehle, Dieter Erath, Stefanie Lanzinger |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-03-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/9/1/e002215.full |
Similar Items
-
An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria
by: Peter Bramlage, et al.
Published: (2023-05-01) -
Diabetes and gender incongruence: frequent mental health issues but comparable metabolic control – a DPV registry study
by: Claudia Boettcher, et al.
Published: (2024-01-01) -
Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database.
by: Hans-Peter Hammes, et al.
Published: (2015-01-01) -
Diabetes management in Wolcott-Rallison syndrome: analysis from the German/Austrian DPV database
by: Alena Welters, et al.
Published: (2020-04-01) -
Clinical characteristics, treatment, and treatment switch after molecular‐genetic classification in individuals with maturity‐onset diabetes of the young: Insights from the multicenter real‐world DPV registry
by: Stefanie Lanzinger, et al.
Published: (2024-11-01)